Lactotripeptides and antihypertensive effects: a critical review
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Hypertension or high blood pressure is a significant health problem worldwide. Typically, lifestyle changes, including adopting a healthy diet, are recommended for people with an elevated blood pressure. Lactotripeptides are bioactive milk peptides with potential antihypertensive properties in man. These peptides, as part of a food product or as nutraceutical, may contribute to the prevention and treatment of hypertension. This paper reviews the current evidence of the blood pressure control properties of lactotripeptides in man. Blood pressure-lowering effects of lactotripeptides are typically measured after 4–6 weeks of treatment. However, in some cases, a blood pressure response has been observed after 1–2 weeks. Maximum blood pressure reductions approximate 13 mmHg (systolic blood pressure) and 8 mmHg (diastolic blood pressure) after active treatment compared with placebo, and are likely reached after 8–12 weeks of treatment. Effective dosages of lactotripeptides range from 3·07 to 52·5 mg/d. Evidence indicates that lactotripeptides are only effective at elevated blood pressure; no further lowering of normal blood pressure has been observed. Concomitant intake of antihypertensive medication does not seem to influence the potency of lactotripeptides to lower blood pressure. Similarly, ethnicity has not been found to influence the extent of lactotripeptide-induced blood pressure lowering. Based on the currently available data, lactotripeptides appear to be safe and effective. Thus, they can be part of a healthy diet and lifestyle to prevent or reduce high blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Gender differences in the regulation of blood pressure
Reckelhoff, J. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1199 · Cited by 1,268 · cited 1×
“After menopause, this relationship no longer exists, and the incidence is comparable in women and men((30)).”
BackgroundLaw, M. R., Wald, N. J., Morris, J. K., & Jordan, R. E. (2003) · BMJ · doi:10.1136/bmj.326.7404.1427 · Cited by 1,232 · cited 2×
“In such settings, BP decreases are also larger at higher starting BP values, although a small residual BPlowering effect is still observed even at normotensive starting values((34)).”
BackgroundResult
Cited by
Sánchez, A., & Vázquez, A. (2017) · Food Quality and Safety · doi:10.1093/fqs/fyx006 · Cited by 868
“Currently, BP and nutraceutical proteins are being developed to improve human health by preventing or alleviating medical conditions such as coronary heart disease, stroke, hypertension, cancer, obesity, diabetes, and osteoporosis (Gilani et al., 2008; Boelsma and Kloek, 2009).”
BackgroundMaersk, M., Belza, A., Stødkilde-Jørgensen, H., Ringgaard, S., Chabanova, E., Thomsen, H., Pedersen, S. B., Astrup, A., & Richelsen, B. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.022533 · Cited by 603
“These findings agree with those of previous studies, in which milk intake was shown to be associated with lower blood pressure, which may have been due to the content of various proteins (eg, lactotripeptides) in milk (8, 32).”
ResultAntihypertensive peptides: Production, bioavailability and incorporation into foods
Hernández-Ledesma, B., del Mar Contreras, M., & Recio, I. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2010.11.001 · Cited by 511
Jenkins, D. J. A., Kendall, C. W. C., Augustin, L. S. A., Mitchell, S., Sahye-Pudaruth, S., Blanco Mejia, S., Chiavaroli, L., Mirrahimi, A., Ireland, C., Bashyam, B., et al. (2012) · Archives of Internal Medicine · doi:10.1001/2013.jamainternmed.70 · Cited by 392
“57 Legume intake, g/d 40 (27-53) 2 (1-4)d 40 (26-54) 211 (185-283)d .”
Antioxidant properties of Milk and dairy products: A comprehensive review of the current knowledge
Khan, I. T., Nadeem, M., Imran, M., Ullah, R., Ajmal, M., & Jaspal, M. H. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0969-8 · Cited by 374
“present in fermented dairy products [101].”
Metadata
- Authors
- Boelsma, E., & Kloek, J.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-12-05
- Volume
- 101
- Issue
- 6
- Pages
- 776-786
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2146918123
- Cited by
- 115
- References
- 4
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactotripeptides and antihypertensive effects: a critical review. https://app.cochat.ai/papers/10.1017/s0007114508137722
- The paper
- Boelsma, E., & Kloek, J. (2008). Lactotripeptides and antihypertensive effects: a critical review. British Journal of Nutrition. https://doi.org/10.1017/s0007114508137722
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.